These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9469795)

  • 21. Glomerular dysfunction in diabetic nephropathy.
    Zucchelli P; Zuccalà A; Sturani A
    Postgrad Med J; 1988; 64 Suppl 3():22-30; discussion 48-9. PubMed ID: 3074295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocyte sodium-lithium countertransport activity and total body insulin-mediated glucose disposal in normoalbuminuric normotensive type 1 (insulin-dependent) diabetic patients.
    Catalano C; Winocour PH; Thomas TH; Walker M; Sum CF; Wilkinson R; Alberti KG
    Diabetologia; 1993 Jan; 36(1):52-6. PubMed ID: 8436253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy.
    Parving HH; Smidt UM; Friisberg B; Bonnevie-Nielsen V; Andersen AR
    Diabetologia; 1981 Apr; 20(4):457-61. PubMed ID: 7016639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.
    Krolewski AS
    Diabetes Care; 2015 Jun; 38(6):954-62. PubMed ID: 25998286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring glomerular function in diabetic nephropathy. A prospective study.
    Viberti GC; Bilous RW; Mackintosh D; Keen H
    Am J Med; 1983 Feb; 74(2):256-64. PubMed ID: 6401924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature cell ageing and evolution of diabetic nephropathy.
    Morocutti A; Earle KA; Rodemann HP; Viberti GC
    Diabetologia; 1997 Feb; 40(2):244-6. PubMed ID: 9049488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
    Ruggenenti P; Perna A; Mosconi L; Pisoni R; Remuzzi G
    Kidney Int; 1998 May; 53(5):1209-16. PubMed ID: 9573535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus.
    Tuttle KR; Bruton JL; Perusek MC; Lancaster JL; Kopp DT; DeFronzo RA
    N Engl J Med; 1991 Jun; 324(23):1626-32. PubMed ID: 2030719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of diabetic nephropathy--is diurnal blood pressure rhythm as important as absolute blood pressure level?
    Farmer CK; Goldsmith DJ; Quin JD; Dallyn P; Cox J; Kingswood JC; Sharpstone P
    Nephrol Dial Transplant; 1998 Mar; 13(3):635-9. PubMed ID: 9550639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol: a renal risk factor in diabetic nephropathy?
    Mulec H; Johnsen SA; Wiklund O; Björck S
    Am J Kidney Dis; 1993 Jul; 22(1):196-201. PubMed ID: 8322783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in erythrocyte sodium-lithium countertransport kinetics in diabetic nephropathy.
    Rutherford PA; Thomas TH; Carr SJ; Taylor R; Wilkinson R
    Clin Sci (Lond); 1992 Mar; 82(3):301-7. PubMed ID: 1312415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium-lithium countertransport in microalbuminuric insulin-dependent diabetic patients.
    Jones SL; Trevisan R; Tariq T; Semplicini A; Mattock M; Walker JD; Nosadini R; Viberti G
    Hypertension; 1990 Jun; 15(6 Pt 1):570-5. PubMed ID: 2347619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control.
    Alaveras AE; Thomas SM; Sagriotis A; Viberti GC
    Nephrol Dial Transplant; 1997; 12 Suppl 2():71-4. PubMed ID: 9269705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clustering of risk factors in hypertensive insulin-dependent diabetics with high sodium-lithium countertransport.
    Trevisan R; Nosadini R; Fioretto P; Semplicini A; Donadon V; Doria A; Nicolosi G; Zanuttini D; Cipollina MR; Lusiani L
    Kidney Int; 1992 Apr; 41(4):855-61. PubMed ID: 1513108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.
    Viberti G; Mogensen CE; Groop LC; Pauls JF
    JAMA; 1994 Jan; 271(4):275-9. PubMed ID: 8295285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.